论文部分内容阅读
目的评价采用小骨窗血肿清除术治疗高血压性脑幕上出血的临床疗效。方法 60例高血压性脑幕上出血患者,按照不同治疗方法分为参照组和治疗组,各30例。参照组采用传统保守治疗方法,治疗组采用小骨窗血肿清除术,对比两组脑血肿完全消失时间和临床效果。结果参照组治疗前欧洲脑卒中评定量表评分为(51.08±1.96)分,治疗2周后为(63.93±4.37)分,治疗4周后为(71.06±5.13)分;治疗组治疗前为(50.86±2.04)分,治疗2周后为(75.48±7.10)分,治疗4周后为(89.87±5.58)分。两组治疗前评分比较,差异无统计学意义(P>0.05),但治疗组治疗2周后与治疗4周后的评分均明显高于参照组,差异有统计学意义(P<0.05)。治疗组脑血肿完全消失时间为(9.35±2.35)d,短于参照组的(16.59±3.40)d,差异具有统计学意义(P<0.05)。结论采用小骨窗血肿清除术治疗高血压性脑幕上出血,有利于改善脑神经功能,效果确切,值得临床优先选择和全面推广。
Objective To evaluate the clinical efficacy of small bone window hematoma in the treatment of hypertensive intracerebral hemorrhage. Methods 60 cases of hypertensive patients with supratentorial hemorrhage were divided into the reference group and the treatment group according to different treatment methods, each 30 cases. The reference group using traditional conservative treatment, the treatment group using small bone window hematoma removal surgery, compared with two groups of complete disappearance of cerebral hematoma and clinical effect. Results The score of European Stroke Scale before treatment (51.08 ± 1.96) was (63.93 ± 4.37) points after treatment for 2 weeks and (71.06 ± 5.13) points after 4 weeks of treatment. The treatment group before treatment was ( 50.86 ± 2.04). After 2 weeks of treatment, it was (75.48 ± 7.10) points, and after 4 weeks of treatment, it was (89.87 ± 5.58) points. There was no significant difference between the two groups before treatment (P> 0.05). However, the scores of two weeks after treatment and four weeks after treatment in the two groups were significantly higher than those in the reference group (P <0.05). The complete disappearance of cerebral hematoma in the treatment group was (9.35 ± 2.35) d, which was shorter than that in the reference group (16.59 ± 3.40) d, the difference was statistically significant (P <0.05). Conclusion The treatment of hypertensive cerebral supratentorial hemorrhage with small bone window hematoma is helpful to improve the function of the cranial nerves and has definite effect. It is worthy of clinical preference and comprehensive promotion.